Castle Creek Biosciences, Llc.
Clinical trials sponsored by Castle Creek Biosciences, Llc., explained in plain language.
-
Gene therapy patch mends wounds in rare 'butterfly skin' disease
Disease control OngoingThis study tests a treatment called D-Fi, made from a patient's own skin cells that are genetically modified to produce a missing protein. It aims to improve wound healing in children and adults with dystrophic epidermolysis bullosa, a condition that causes fragile, blistering sk…
Phase: PHASE3 • Sponsor: Castle Creek Biosciences, LLC. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Gene therapy shows promise for rare 'Butterfly Skin' wounds
Disease control OngoingThis study tests a gene therapy called FCX-007 for people with recessive dystrophic epidermolysis bullosa (RDEB), a rare skin condition causing severe blistering. The treatment uses the patient's own skin cells, modified to produce a missing protein, and is injected into wounds. …
Phase: PHASE3 • Sponsor: Castle Creek Biosciences, LLC. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC